文献速递神经肿瘤

垂体腺瘤的代谢在体可视化:影像模态的系统综述

Metabolic In Vivo Visualization of Pituitary Adenomas: a Systematic Review of Imaging Modalities.
PubMed 文献 · World Neurosurg · 2017-04-28

本系统综述检索PubMed数据库,纳入25项使用PET、MRS和SPECT成像垂体腺瘤的研究,评估各模态的诊断准确性。PET可可靠检出垂体腺瘤,尤其在MRI结果不明确时,但受高成本和低可及性限制;MRS consistently检测细胞增殖和激素活性,但需更高磁场强度进一步研究。

要点

  • PET可可靠检出垂体腺瘤,尤其在MRI结果不明确时,但受高成本和低可及性限制。
  • SPECT对神经内分泌肿瘤敏感性好,但其在垂体腺瘤中的应用文献记录不足。
  • MRS可稳定检测细胞增殖和激素活性,但需更高磁场强度进一步研究。

核心结论

  • PET和MRS在检测垂体腺瘤方面似乎具有最强的预测价值。
  • MRS具有低成本优势,但文献缺乏针对垂体的特异性研究。
  • 由于功能性垂体腺瘤复发率高且现有诊断检查敏感性低,有必要进一步研究代谢成像。

研究设计与样本

  • 对PubMed数据库自建库以来关于垂体腺瘤的影像学研究进行系统综述。
  • 应用排除标准后,共回顾25项使用PET、MRS和SPECT成像垂体腺瘤的研究。
  • 收集研究特征、临床症状、影像模态和诊断准确性数据。

主要发现

  • PET可可靠检出垂体腺瘤,尤其在MRI结果不明确时,但其效能受高成本和低可及性限制。
  • SPECT对神经内分泌肿瘤具有良好敏感性,但其在垂体腺瘤中的应用文献记录不足。
  • MRS可稳定检测细胞增殖和激素活性,但需在更高磁场强度下进一步研究。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • PET的效能受高成本和低可及性限制。
  • SPECT在垂体腺瘤中的应用文献记录不足。
  • MRS需在更高磁场强度下进一步研究。
  • 文献缺乏针对垂体的特异性MRS研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pituitary adenomas (PAs) are the most common intrasellar mass. Functional PAs constitute most of pituitary tumors and can produce symptoms related to hormonal overproduction. Timely and accurate detection is therefore of vital importance to prevent potentially irreversible sequelae. Magnetic resonance imaging is the gold standard for detecting PAs, but is limited by poor sensitivity for microadenomas and an inability to differentiate scar tissue from tumor residual or predict treatment response. Several new modalities that detect PAs have been proposed. METHODS: A systematic review of the PubMed database was performed for imaging studies of PAs since its inception. Data concerning study characteristics, clinical symptoms, imaging modalities, and diagnostic accuracy were collected. RESULTS: After applying exclusion criteria, 25 studies of imaging PAs using positron emission tomography (PET), magnetic resonance spectroscopy (MRS), and single photon emission computed tomography were reviewed. PET reliably detects PAs, particularly where magnetic resonance imaging is equivocal, although its efficacy is limited by high cost and low availability. Single photon emission computed tomography possesses good sensitivity for neuroendocrine tumors but its use with PAs is poorly documented. MRS consistently detects cellular proliferation and hormonal activity, but warrants further study at higher magnetic field strength. CONCLUSIONS: PET and MRS appear to have the strongest predictive value in detecting PAs. MRS has the advantage of low cost, but the literature is lacking in specific studies of the pituitary. Due to high recurrence rates of functional PAs and low sensitivity of existing diagnostic workups, further investigation of metabolic imaging is necessary.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Yao A, Balchandani P, Shrivastava RK, et al. Metabolic In Vivo Visualization of Pituitary Adenomas: a Systematic Review of Imaging Modalities. World Neurosurg. 2017. PMID: 28461279. doi:10.1016/j.wneu.2017.04.128

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。